Jane Street’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Sell |
10,737
-64,449
| -86% | -$901K | ﹤0.01% | 4869 |
|
|
2025
Q1 | $1.01M | Buy |
75,186
+27,164
| +57% | +$366K | ﹤0.01% | 3045 |
|
|
2024
Q4 | $921K | Sell |
48,022
-303,131
| -86% | -$5.81M | ﹤0.01% | 3064 |
|
|
2024
Q3 | $7.99M | Buy |
351,153
+238,078
| +211% | +$5.42M | ﹤0.01% | 902 |
|
|
2024
Q2 | $1.47M | Buy |
113,075
+63,393
| +128% | +$825K | ﹤0.01% | 3144 |
|
|
2024
Q1 | $870K | Sell |
49,682
-18,286
| -27% | -$320K | ﹤0.01% | 3381 |
|
|
2023
Q4 | $1.48M | Buy |
67,968
+8,332
| +14% | +$181K | ﹤0.01% | 2843 |
|
|
2023
Q3 | $915K | Sell |
59,636
-140,113
| -70% | -$2.15M | ﹤0.01% | 2997 |
|
|
2023
Q2 | $4.75M | Buy |
199,749
+156,704
| +364% | +$3.73M | ﹤0.01% | 1548 |
|
|
2023
Q1 | $1.1M | Buy |
+43,045
| New | +$1.1M | ﹤0.01% | 2698 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6322 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6409 |
|
|
2022
Q2 | – | Sell |
-61,518
| Closed | -$1.14M | – | 6334 |
|
|
2022
Q1 | $1.14M | Buy |
+61,518
| New | +$1.14M | ﹤0.01% | 2800 |
|
|
2019
Q3 | – | Sell |
-5,174
| Closed | -$159K | – | 4043 |
|
|
2019
Q2 | $159K | Buy |
+5,174
| New | +$159K | ﹤0.01% | 3182 |
|
|
2018
Q2 | – | Sell |
-672
| Closed | -$71K | – | 3780 |
|
|
2018
Q1 | $71K | Buy |
+672
| New | +$71K | ﹤0.01% | 2966 |
|